NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · IEX Real-Time Price · USD
1.160
0.00 (0.00%)
Apr 25, 2024, 9:30 AM EDT - Market open
Company Description
NeuroOne Medical Technologies Corporation operates as a medical technology company.
The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.
It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator.
The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 16 |
| CEO | David A. Rosa M.D. |
Contact Details
Address: 7599 Anagram Dr Eden Prairie, Minnesota 55344 United States | |
| Phone | (952) 426-1383 |
| Website | nmtc1.com |
Stock Details
| Ticker Symbol | NMTC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001500198 |
| CUSIP Number | 64130M209 |
| ISIN Number | US64130M2098 |
| Employer ID | 27-0863354 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Rosa M.D. | President, Chief Executive Officer and Director |
| Ronald W. McClurg | Chief Financial Officer |
| Steven Mertens | Chief Technology Officer |
| Mark Christianson | Co-Founder, Business Development Director and Medical Sales Liaison |
| Christopher R. Volker CFA | Chief Operating Officer |
| Hijaz Haris | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 26, 2024 | 8-K | Current Report |
| Mar 15, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | 8-K | Current Report |
| Feb 13, 2024 | 10-Q | Quarterly Report |
| Jan 31, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jan 29, 2024 | ARS | Filing |
| Jan 29, 2024 | DEF 14A | Other definitive proxy statements |
| Jan 29, 2024 | SCHEDULE 13G | Filing |
| Jan 11, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |